NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a
class action lawsuit has been filed against Immunomedics, Inc. ("Immunomedics" or the "Company") (NASDAQ: IMMU) and certain of its
officers, on behalf of shareholders who purchased or otherwise acquired Immunomedics shares between February 8, 2018 and November
6, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
bgandg.com/immu.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the
Securities Exchange Act of 1934.
The Complaint alleges that on December 17, 2018, FDAnews.com published an article entitled “FDA Hits Immunomedics for Data Integrity
Breach.” The article reported, in part, that “[t]he FDA cited Immunomedics for a host of violations—including its handling of
a data integrity breach—observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”
The article further stated that the data breach included “manipulated bioburden samples, misrepresentation of an integrity
test procedure in the batch record, and backdating of batch records, such as dates of analytical results.” Following
publication of this article, Immunomedics’ stock price fell sharply, damaging investors.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s
site: bgandg.com/immu or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst,
Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Immunomedics you have until February
25, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class
action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
